— Know what they know.
Not Investment Advice

DICE NASDAQ

DICE Therapeutics, Inc.
1W: +0.0% 1M: +1.7% 3M: +45.0% 1Y: +143.0%
$47.55
Last traded 2023-08-18 — delisted
NASDAQ · Healthcare · Biotechnology · $2.3B mcap · Short 87% of daily vol

Balance Sheet Trends

Total Assets
$594M +82.3% ▲
3Y CAGR: +167.1%
Total Liabilities
$27M +110.8% ▲
3Y CAGR: -23.7%
Shareholders Equity
-$188M -80.9% ▼
Cash & Investments
$574M +79.8% ▲
3Y CAGR: +178.3%
Total Debt
$13M +453.6% ▲
3Y CAGR: +290.9%
Net Debt
-$448M -295.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022
— Assets —
Cash$8M$60M$116M$461M
Short-Term Investments$18M$0$203M$113M
Cash & ST Investments$27M$60M$319M$574M
Net Receivables$2M$2M$2M$0
Inventory$0$0$0$0
Other Current Assets$0$0$3M$4M
Total Current Assets$29M$62M$324M$578M
Property, Plant & Equip.$2M$2M$2M$16M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Other Non-Current Assets$161K$154K$198K$198K
Total Non-Current Assets$2M$2M$2M$16M
Total Assets$31M$64M$326M$594M
— Liabilities —
Accounts Payable$1M$5M$2M$3M
Short-Term Debt$123K$98K$480K$1M
Deferred Revenue$863K$1M$0$0
Other Current Liabilities$2M$3M$9M$11M
Total Current Liabilities$4M$9M$11M$15M
Long-Term Debt$99K$0$2M$12M
Other Non-Current Liab.$56M$0$8K$0
Total Non-Current Liabilities$57M$108M$2M$12M
Total Liabilities$61M$117M$13M$27M
— Equity —
Common Stock$0$0$4K$5K
Retained Earnings-$31M-$55M-$104M-$188M
Accumulated OCI$8K$0-$58K-$597K
Total Stockholders Equity-$30M-$53M-$104M-$188M
Total Liabilities & Equity$31M$64M-$91M-$161M
— Key Metrics —
Total Debt$222K$98K$2M$13M
Net Debt-$8M-$60M-$113M-$448M
Total Investments$18M$0$203M$113M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms